
Met-GL 1mg Tablet SR
Marketer
West-Coast Pharmaceutical Works Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Met-GL 1mg Tablet SR
GlucoMet 1mg Extended-Release tablets are classified as antidiabetic agents, a dual-medication formulation for managing type 2 diabetes in adults. This medication aids in regulating blood glucose. GlucoMet 1mg ER should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe renal or hepatic impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Met-GL 1mg Tablet SR
No text provided to rephrase.
Uses of Met-GL 1mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Met-GL 1mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met-GL 1mg Tablet SR should be administered with a meal.
Common Side effects of Met-GL 1mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Met-GL 1mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met-GL 1mg sustained-release tablet should be taken with meals.
How Met-GL 1mg Tablet SR works:
Metformin/Glimepiride 1mg Extended-Release tablets combine two diabetes medications to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Met-GL 1mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Met-GL 1mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Sustained-release Met-GL 1mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Met-GL 1mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Met-GL 1mg Tablet SR use. Consult a physician. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Exercise caution when administering Met-GL 1mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. For patients exhibiting mild to moderate liver disease, Met-GL 1mg Tablet SR should typically commence at a reduced dosage; its use is contraindicated in those with severe liver dysfunction.
What if you forget to take Met-GL 1mg Tablet SR :
Should you forget a Met-GL 1mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Met-GL 1mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
